SILVER SPRING, Md., June 26 (Reuters) - River Plate Biotechnology did not provide adequate evidence of safety and effectiveness for a proposed drug to treat dry eye, a U.S. advisory panel ruled on Friday.
The committee voted 6-1 against the drug, called Rejena. Alcon Inc (ACL.N) holds U.S. marketing rights for the product.
(Reporting by Lisa Richwine)
NEW YORK/HOUSTON/BEIJING (Reuters) - Saudi Arabia has quit a long-held lease for 5 million barrels of Caribbean oil storage near the key U.S. market and state giant PetroChina is poised to move in, industry sources say, a potentially major shift in global oil trade dynamics.
The Dutch are doing it. So what's taking the U.S. so long to make airport body scanners mandatory? Full Article | Video
Bernie Madoff became the poster boy of crooked investment schemes this year -- but he wasn't alone. Here's a look at the 10 most notorious cases of 2009. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
